These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24732905)

  • 21. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report.
    Ghio L; Ferraresso M; Giani M; Mihatsch M; Edefonti A
    Transplant Proc; 2004 Jun; 36(5):1332-5. PubMed ID: 15251325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
    Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case report of colchicine-induced myopathy in a patient with chronic kidney disease].
    DU YJ; Liu WC; Chen X; Cheng YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1188-1190. PubMed ID: 34916703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients.
    Rana SS; Giuliani MJ; Oddis CV; Lacomis D
    Clin Neurol Neurosurg; 1997 Dec; 99(4):266-70. PubMed ID: 9491303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients.
    de Jonge H; de Loor H; Verbeke K; Vanrenterghem Y; Kuypers DR
    Clin Pharmacol Ther; 2011 Sep; 90(3):414-22. PubMed ID: 21753749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
    Xenos EX; Ciancio G; Burke GW; Roth D; Miller J
    Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of recurrent episodes of rhabdomyolysis with tacrolimus in a transplant recipient with myopathy.
    Sathyan S; Baskharoun R; Perlman AS
    Am J Ther; 2014; 21(5):e171-4. PubMed ID: 23429166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diltiazem use in tacrolimus-treated renal transplant recipients.
    Kothari J; Nash M; Zaltzman J; Ramesh Prasad GV
    J Clin Pharm Ther; 2004 Oct; 29(5):425-30. PubMed ID: 15482385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic human colchicine myopathy].
    Iwatsubo T; Ishige Y; Nukina N; Mannen T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):1001-4. PubMed ID: 2265497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine: serious interactions.
    Prescrire Int; 2008 Aug; 17(96):151-3. PubMed ID: 19492485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is myopathy in renal transplant patients induced by cyclosporin or colchicine?
    Rumpf KW; Henning HV
    Lancet; 1990 Mar; 335(8692):800-1. PubMed ID: 1969550
    [No Abstract]   [Full Text] [Related]  

  • 36. A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
    Prasad GV; Nash MM; Keough-Ryan T; Shapiro RJ
    J Nephrol; 2010; 23(3):274-81. PubMed ID: 20383867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colchicine myopathy and neuropathy.
    Kuncl RW; Duncan G; Watson D; Alderson K; Rogawski MA; Peper M
    N Engl J Med; 1987 Jun; 316(25):1562-8. PubMed ID: 3035372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colchicine neuromyopathy: a report of six cases.
    Altiparmak MR; Pamuk ON; Pamuk GE; Hamuryudan V; Ataman R; Serdengecti K
    Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S13-6. PubMed ID: 12371628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.